Publications
Showing 41 to 50 of 540 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria | Ismail, Z., Gatchel, J., Bateman, D. R., Barcelos-Ferreira, R., Chantillon, M., Jaeger, J., Donovan, N. J., & Mortby, M. E. | 2017 | International Psychogeriatrics |
| Age at Onset of Parkinson’s Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations | Yahalom G, Rigbi A, Israeli-Korn S, Krohn L, Rudakou U, Ruskey JA, Benshimol L, Tsafnat T, Gan-Or Z*, Hassin-Baer S, Greenbaum L | 2020 | Journal of Parkinson's Disease |
| Age-related deregulation of TDP-43 after stroke enhances NF-kappaB-mediated inflammation and neuronal damage | Thammisetty, S.S., Pedragosa, J., Weng, Y.C., Calon, F.**, Planas, A., Kriz, J.** | 2018 | Journal of Neuroinflammation |
| Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V.*, Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
| Ageism and COVID-19: What does our society’s response say about us? | Fraser S*, Lagacé M, Bongué B, Ndeye N, Guyot J, Bechard L**, Garcia L, Taler V, CCNA Social Inclusion and Stigma Working Group, Adam S, Beaulieu M, Bergeron CD, Boudjemadi V, Desmette D, Donizzetti AR, Éthier S, Garon S, Gillis M, Levasseur M, Lortie-Lussier M, Marier P, Robitaille A, Sawchuk K, Lafontaine C, Tougas F. | 2020 | Age and Ageing |
| Ageism and COVID-19: what does our society’s response say about us? | Fraser, S.*, Lagacé, M*, Bongué, B., Ndeye, N., Guyot, J., Bechard, L.**, Garcia, L., Taler, V., Members of the CCNA Social Inclusion and Stigma Working Group*, Adam, S., Beaulieu, M., Bergeron, C.D., Boudjemadi, V., Desmette, D., Donizzetti, A. R., Éthier, S., Garon, S., Gillis, M., Levasseur, M., Lortie-Lussier, M., Marier, P., Robitaille, A., Sawchuk, K., Lafontaine, C., & Tougas, F. | 2020 | Age and Ageing |
| Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation | Ruthirakuhan M, Herrmann N*, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE*, Kiss A, Lanctôt KL* | 2019 | Geriatr Psychiatry Neurol |
| Allocating Scarce Resources to Persons with Dementia During a Pandemic | Smith EE, Couillard P, Fisk JD, Ismail Z, Montero-Odasso M, Robillard J, Vedel I, Sivananthan S, Gauthier S. | 2020 | Canadian Geriatrics Journal |
| Alzheimer Disease, biomarkers, and clinical symptoms – Quo Vadis? | Montero-Odasso M*, Ismail Z*, Camicioli R* | 2020 | JAMA Neurology |
| Alzheimer’s Disease Neuroimaging Initiative. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease. | Pascoal T.A.**, Mathotaarachchi S.**, Shin M.**, Park A.Y., Mohades S., Benedet A.L.**, Kang M.S., Massarweh G., Soucy J.P.**, Gauthier S.**, Rosa-Neto P.** | 2018 | European Journal of Nuclear Medicine and Molecular Imaging |
Showing 41 to 50 of 540 Publications